Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441497 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
BM positivity was associated with unfavourable biological factors and might represent more aggressive tumours. Patients with qPCR positive BM should not be upstaged, because of very few systemic events in the cohort. However, for patients with more than one marker positive a more careful follow-up is advisable. These results need to be verified in a very large cohort of localised patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Esther M. van Wezel, Boris Decarolis, Janine Stutterheim, Lily Zappeij-Kannegieter, Frank Berthold, Roswitha Schumacher-Kuckelkorn, Thorsten Simon, Marta Fiocco, Max M. van Noesel, Huib N. Caron, C. Ellen van der Schoot, Barbara Hero,